Apolipoprotein(a) gene polymorphism in the Korean population: is there any relevance to essential hypertension?
To investigate the role of the apolipoprotein(a) [Apo(a)] gene in predicting essential hypertension in the Korean population, we undertook a case-control study using the TTTTA repeat and the Met/Thr polymorphisms of the Apo(a) gene. The study subjects consisted of 74 essential hypertensives and 211 normotensive individuals. For polymorphism analysis, DNA was amplified by polymerase chain reaction (PCR). In the case of the Met/Thr polymorphism, amplified PCR products were digested with the restriction enzyme Kspl. Genotyping was performed by a 10% nondenaturing polyacrylamide gel. There were no significant differences in the allele and genotype frequencies of these polymorphisms between normotensive and essential hypertensive subjects (p > 0.05). Furthermore, levels of lipoprotein(a) in the plasma were not significantly associated with the different genotypes of the APO(a) gene in either group (p > 0.05). The polymorphisms of these two loci on the Apo(a) gene are unlikely to contribute to the etiology of essential hypertension in the Korean population.